Background: There is increasing concern about opioid use as a pain treatment option among older adults. Existing literature implies an association between opioid use and fracture, increasing the risk of death and disabilities; yet, this relationship with other fall-related outcomes has not been fully explored. We performed a meta-analysis to evaluate the associations between opioid use and adverse health outcomes of falls, fall injuries, and fractures among older adults.
A c c e p t e d M a n u s c r i p t 3 opioid education and non-opioid related pain management interventions among older adults to decrease fall-related risk.
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Background
Opioid as a pain treatment option among older adults is a public health concern. The use of prescribed opioid analgesics among middle-aged and older adults is more prevalent (8.1% of adults aged 40-59 and 7.9% of adults aged 60 and over) than that of younger adults (4.7% of adults aged 20-39) (1) . Moreover, one-fourth (25.4%) of adults aged 65 years and older who are taking opioids report being long-time opioid users for a period of 90 days or longer (2) . The high prevalence of opioid use among older adults can be explained by the high prevalence of chronic pain among older adults and the more widespread use of opioids to manage acute and chronic pain. Currently, over half of older adults (52.9%) experience bothersome pain (3) . Pain prevalence is high among older adults who are female, obese, and having musculoskeletal and depressive symptoms.
Research has shown the association between medication use, especially psychotropic and benzodiazepine drugs, and falls (4-6) and fall-related fractures (7) among older adults. The American Geriatrics Society Beers Criteria Update Expert Panel (8) has advised that opioids be used only for severe acute pain due to increased risks of falls and fractures and issued warnings about the adverse risk of overdose due to polypharmacy (i.e., an opioid with other central nervous system active medications). The associations of opioids with fractures (9, 10) have been found in some meta-analysis studies. However, the associations of opioid use with falls were inconsistent in meta-analyses (5, 6, 11) . A recent meta-analysis, which examined associations of A c c e p t e d M a n u s c r i p t 4 psychotropic and cardiovascular medications, found a positive association between opioid use and falls (OR = 1.60, 95 CI: 1.35, 1.91) (12). However, risk estimates of different fall-related outcomes (i.e., falls, fall injuries, and fractures) associated with opioids among older adults have not been fully explored in the one systematic review and meta-analysis. Since falls are the leading cause of injury, premature death, and diminished quality of life among adults aged 65 years or older (13) , it is critical to identify the magnitude of risk of opioid use on falls, fall injuries, and fractures.
The purposes of this study were to systematically review characteristics of the studies examining opioid use on falls, fall injuries, and fractures among older adults and summarize the magnitude of the effect of opioid use on these adverse health outcomes. The specific objectives were to: (1) evaluate the association of opioid use on fall-related adverse risk (i.e., falls, fall injuries, and fractures); (2) examine differences in the association of opioid use on fall-related adverse risk by analysis method, study design, setting, and study quality; and (3) explore the association of opioid use on fall-related adverse risk by dosage.
Methods
Study selection and inclusion criteria
This study was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline (14) subject headings as appropriate along with synonyms for each term: fall, opioids, narcotics, and aged (see Supplementary Appendix 2) . We also conducted a cross-reference search by reviewing the references of relevant articles, which yielded additional eligible studies.
The following inclusion criteria were set for identifying studies that answer our research questions: (1) aged ≥ 65 or at least older adults as a group of general populations (i.e., the studies that categorized participants into "older adults" as compared with younger participants); (2) opioids as the exposure of interest; (3) outcome variables of fall or fall injury or/and fracture; (4) used case-control or cohort design; (5) analyzed data quantitatively; (6) provided relative risks (RR), odds ratios (OR), or hazard ratios (HR); and (7) published in English language. Clinical trials and conference proceedings were covered in the search of Cochrane CENTRAL, which included WHO International Clinical Trials Registry Platform, and ClinicalTrials.gov, and Northern Light Life Sciences Conference Abstracts. We excluded studies that used crosssectional designs because of insufficient inference of causality. Citations were retrieved and added to Rayyan, an online tool for sorting citations (15) . Two investigators (AY and SJ) independently evaluated the eligibility of all the studies retrieved from the databases based on title and abstract. Any disagreements were resolved by a consensus-based discussion. The final decisions about inclusion or exclusion of the identified studies were then assessed by the two investigators through full-text screening.
Data extraction and quality assessment
The following information was extracted from the identified studies: the first author's name, the year of publication, study design, analysis method (i.e., HR, RR, or OR), country, characteristics of participants, the number of participants, age range of the participants, setting A c c e p t e d M a n u s c r i p t 6 (e.g., community, hospital, population), type of opioid exposure, outcome type (e.g., falls, fall injuries, and fractures), data sources, and covariates adjustment.
The methodological and reporting quality of the identified studies was assessed by two investigators (AY and SA) based on the Newcastle -Ottawa Scale (NOS) (16) . The NOS is a commonly used checklist that was developed for non-randomized studies (i.e., cohort and casecontrol studies). The instrument, which consists of eight items, assesses the study quality based on three domains: selection, comparability, and outcome for cohort studies or exposure for casecontrol studies (see Supplementary Appendix 3). The higher scores indicate high-quality studies (scores ≥7 as a high-quality study on the original scale) (57) . We categorized the identified studies into high and low-quality studies, and subgroup analysis was conducted based on the methodological and report quality (low-quality versus high-quality). Any disagreements on rating were resolved by a consensus-based discussion or a third investigator.
Data analysis
The studies varied in reported analysis methods (i.e., OR, RR, and HR), and effect sizes were log-transformed to make them comparable across the studies (17) . To test for the association between opioid use and the risk of falls, fall injuries, and fractures, we then pooled risk estimates and corresponding 95 % confidence of intervals (CI) in the identified studies using random-effect models. In this meta-analysis, we excluded four studies that potentially used the same datasets after having examined the year and location of data in the identified 30 studies.
We included only one study that potentially used the same dataset to avoid a lack of statistical independence and inflation of the results (18) . The I 2 statistics were estimated to evaluate the statistical heterogeneity. The values of 25%, 50%, and 75% are considered as small, moderate, A c c e p t e d M a n u s c r i p t 7 and large levels of heterogeneity, respectively (19) . To explore the potential reasons for heterogeneity, we performed meta-regression by including potential moderators: analysis method, study design, setting (participants' characteristics) and study quality for each of the outcomes (i.e., falls, fall injuries, and fractures) separately. We conducted Egger's test, which is suitable for small numbers of studies, for assessing bias (20) . Then, we performed a sensitivity analysis investigating the effect of differential opioid dosage on fractures. Since we lacked a sufficient number of studies to examine the pattern of the risks for falls or fall injuries by dosages, our sensitivity analysis was limited to fractures. All statistical analyses were performed with STATA, version 16.0 (Stata Corp, College Station, TX, USA).
Results
A total of 2,494 articles were identified in the initial search through databases. Of these, 2,428 unrelated studies or articles were excluded after reviewing the titles and abstracts. We included 12 studies, which were identified by cross-referencing, resulting in 78 studies that had a full-text review. We excluded 42 studies after reading the full text for a number of reasons including: unrelated topics, review papers or commentary studies, studies using cross-sectional design, and studies using the same dataset. We identified 36 studies in the systematic review and then excluded six studies that provided inefficient information for estimating effect sizes (i.e., OR, RR, HR) or potentially used the overlapped data in the meta-analysis ( Figure 1 ).
Among the 36 studies, 20 were cohort studies, which consist of 15 prospective and five retrospective cohort designs, and 16 were case-control studies. The detailed characteristics of the identified 36 studies and references are presented in Supplemental Table 1 . For collecting information about fall-related adverse events, the majority of studies (83.3%) utilized either A c c e p t e d M a n u s c r i p t 8 national registry data (n = 15), such as universal health system and Medicare records, or medical records and incident reports collected by doctors, nurses at hospital, nursing homes, or care facilities for older adults (n = 15). Six studies (16.7%) used self-report for collecting information about fall-related outcomes. About 42% of the identified studies were population-based (n = 15), followed by hospital (n = 9) and community (n = 7) settings. Five studies were conducted at care facilities, such as nursing homes and long-term care facilities. Ten studies (27.8%) involved study participants with specific health conditions: osteoarthritis, osteoporosis or rheumatoid arthritis (27, 28, 31, 35, 41, 47) , intellectual disability (21), humerus fracture (22), dementia (29, 56) , and knee or hip arthroplasty (47) . Four studies included only males (35, 54) or females (27, 28) . The identified studies were conducted in various countries: USA (n = 15), Canada (n = 5), Sweden (n = 6), Taiwan (n = 2), UK (n = 2), Australia (n = 1), France (n = 1), Finland (n = 1), The Netherlands (n = 1), Singapore (n = 1), and Colombia (n = 1). The sample sizes of the studies differ substantially from 124 in the study of hospitalized patients (53) to 403,339 in the population-based cohort study (23) .
The total score of methodological and reporting quality of the studies based on NOS in the identified studies ranged from 5 to 9, with mean values of 8.06 for the case-control studies and 6.75 for cohort studies (Supplemental Table 2 ). Thirty of the 36 studies (83.33%) are considered as good quality studies by having scored at least seven or greater (57) . The identified studies exhibited good quality in the domains of selection. Case-control and cohort studies, however, differed in the score of the domain of outcome. The case-control studies scored the good or fair quality for the outcome domain, while the cohort studies had much lower scores from one to two, indicating poor to fair quality. The lower scores in the outcome domain among A c c e p t e d M a n u s c r i p t 9 the cohort studies resulted from the type of data used (i.e., self-report rather than record linkage) and insufficient information of the follow-up.
Meta-analysis
Before investigating differences in the associations between opioid use and health outcomes, we computed the logged transformed effect sizes of 34 effect sizes in the 30 identified studies to explore if there are significant differences in the effect sizes by analysis method (i.e., HR, OR, RR) (Supplemental figure 1) . The log-transformed effect sizes were 0.39 (95% CI: 0.23, 0.54) for HR, 0.53 (95% CI: 0.33, 0.73) for OR, and 0.28 (95% CI: 0.09, 0.46) for RR with the large levels of heterogeneity (HR: I 2 = 97.5%, OR: I 2 = 79.4%, RR: I 2 = 78.6%). While the large levels of heterogeneity were found within groups, there were no significant differences in the transformed effect sizes by analysis method (F2, 33 = 2.43, p = 0.10). Because the logtransformed effect sizes did not significantly differ by analysis method, we used the transformed effect sizes for further analyses.
Effects of opioid use on falls, fall injuries and fractures
Opioid use was associated with the occurrence of fall-related adverse events: falls, fall injuries, and fractures ( Figure 2 ). Although differences in effect sizes were not statistically significant by fall-related outcomes (F2, 33 = 2.34, p = 0.11), the effects of opioid use on the incidence of falls appeared to be smaller (ES = 0.15, 95% CI: 0.02, 0.27) compared to those of fall injury (ES = 0.40, 95% CI: 0.24, 0.56) and fracture (ES = 0.71, 95% CI: 0.45, 0.97).
Moderate (Fall: I 2 = 43.1%) to large (Fracture: I 2 = 89.0%; Fall injury: I 2 = 98.0%) levels of heterogeneity were confirmed. Moreover, we found no differences in the transformed effect sizes by analysis method, study design, setting, and the quality of a study (Supplemental Table 3 ). No A c c e p t e d M a n u s c r i p t 10 evidence of bias was detected across the three outcomes: falls (p = 0. 08), fall injuries (p = 0.15), and fractures (p = 0.13) (for Funnel plots, see Supplementary Figure 2 ).
Effect of opioid use on fracture by dosage
The log-transformed effect sizes of the three studies that reported differential effects of opioid use on fracture or hip fracture by dosage level are presented in Figure 3 . The types of opioids and category criteria (i.e., mg per day) were not consistent among the included three studies; therefore, a subgroup analysis was not performed. Although statistical significance was not obtained, the dosage appeared to be associated with the risk of fracture (ES = 0.76 95% CI: 0.45, 1.08). As indicated in the forest plot (Figure 3 ), the older adults who took higher dosages of opioids per day appeared to have a higher risk of fractures, with ES ranging from 0.18 to 1.63.
Discussion
The purpose of this study was to determine if there was an association between opioid use and falls, fall injuries and fractures among older adults. The 36 studies in the systematic review, consisting of case-control and cohort studies, involved a wide range of study settings, sample sizes, and data types in various countries. The present study has expanded upon previous relevant meta-analyses by evaluating multiple fall-related outcomes in the one systematic review.
Our systematic review found that opioid use was associated with falls, falls injuries, and fractures. The sample sizes substantially differed across the studies. Despite the large level of heterogeneity, the meta-analysis of 34 effect sizes in the identified 30 studies shows that there is an association between opioid use and falls, falls injuries and fractures among older adults.
Although statistical significance was not observed for effect sizes between the three outcomes, an association between opioid use and fractures risk appears to be stronger than the association Our findings of the significant association between opioids and fracture are consistent with the reports of previous meta-analyses (9, 10). Similarly, our findings are similar to the recent systematic review that examined the effect of opioids on fall injuries (12). Despite the inconsistent findings of association between opioid use and falls (5, 6, 11) , the present study, which contains the recent studies published in the past three years, found a marginal yet a significant association between opioid use and falls (ES = 0.15, 95% CI: 0.02, 0.27) with moderate heterogeneity (I 2 = 43.1%). The present study paid a particular attention to the risks of different fall-related outcomes associated with opioid use, and thereby advancing existing knowledge. The selected moderators (i.e., analysis method, study design, setting, study quality) did not explain variability in the transformed effect sizes among fall, fall injuries and fractures.
Further investigation is needed to better understand the effect of analysis method among fallrelated adverse conditions.
Strengths and limitations
The major strength of this study is that we examined multiple fall-related adverse conditions. The previous reviews primarily focused on the association between opioid and fractures; thus, the differential associations of opioids with falls and fall injuries have been adverse conditions attributed to opioid use. To our knowledge, this is the first meta-analysis that focused on the evaluation of different levels of fall-related outcomes: falls, fall injury, and fractures.
Another strength is the broader review that covers relevant literature by including the term "narcotic" into a systematic screening. Previous reviews used the search terms either "opioid," "opiate," or "narcotic" as keywords representing exposure (5, 9, 10, 12) . We included all three terms in the present review because opioids and narcotics have been used interchangeably in clinical settings. Having included studies with relatively good quality evaluated by the standardized assessment tool (i.e., the Newcastle -Ottawa Scale) is another strength. A vast majority of the studies (85%) was identified as a good quality in terms of methodology and report. The inclusion of the high-quality studies would help support good quality evidence. Finally, the present study highlights the dosage effects of opioid use on fractures and hip fractures in the sensitivity analysis. Although a subgroup analysis by dosage level was not attainable due to the inconsistent type of opioids and dosages, the forest plot (i.e., based on log transform effect sizes all adjusted covariates) provides a visual pattern of dosage effects on the relationship between opioid and fractures and hip fractures.
A limitation of this study is the large level of heterogeneity in effect sizes among the identified studies. Our findings of meta-regression did not provide sufficient evidence to explain the large heterogeneity, except the factor of analysis method in the studies of fall injuries. The observed heterogeneity in this study could be attributed to conceptual and methodological reasons. Conceptually, the three conditions of falls, fall injuries, and fractures are not mutually exclusive. Fracture is a subset of fall injury, which is a subset of fall. Although we paid attention to the definitions and descriptions of fall-related adverse conditions in each study, the A c c e p t e d M a n u s c r i p t 13 classification might not be clear especially in the studies that collected information from participants through self-report. Moreover, as illustrated in the summary table of study characteristics, methodological factors (e.g., sample size, female ratio) could be a source of heterogeneity. We limited inclusion to English studies and published work, which potentially omitted relevant studies and could lead to publication bias. Furthermore, there may be unknown moderators that we did not include in our analyses.
Another limitation is the potential risk of inflated effect size estimates due to the inclusion of the studies that may have used the same data sources. We examined the location and time period of data sources among the 36 studies and excluded the four studies that potentially overlap the data sources prior to meta-analysis. However, the three studies (22, 41, 47) reported limited information about the location of data collected, suggesting a potential risk of including the same data sources.
The present study also had a limited scope of sensitivity analysis because of insufficient information reported in the identified studies. A few studies reported effect sizes by the duration of opioid use, so we could not perform sensitivity analysis investigating the differential effects of opioids on fall-related health outcomes by usage duration. We instead identified three relevant studies and examined the effect of the differential opioid dosages on fracture/hip fracture.
Future implications
For practice implications, study findings highlight the need for refined clinical guidelines for opioid prescriptions and additional clinical education to address adverse fall-related events and health consequences associated with opioid use. Moreover, our findings, which highlight different severity of fall-related consequences associated with opioid use, bring attention to the A c c e p t e d M a n u s c r i p t 14 need for effective opioid education and alternative pain treatments for older adults. The risk of opioid use and related adverse health outcomes for older adults could be addressed through community-based education programs directed toward older adults, such as fall prevention and alternative pain management programs.
For research implications, the critical processes of subgroup analyses due to the large level of heterogeneity were illuminated in the present study. A series of subgroup analyses based on the log-transformed effect sizes revealed no significant differences by analysis method, study design, setting, the quality of a study, and covariate adjustment. Of the 36 studies included in the present study, more than 40% (n = 15) were conducted in the United States, eleven from Europe (Sweden, France, the Netherlands, UK, and Finland), five from Canada, three from Asia (Taiwan, Singapore), one from Oceania (Australia), one from Central America (Colombia), and none from Sub-Saharan Africa. Given opioid use is a worldwide public health issue, additional studies are needed to fully investigate this global phenomenon. The identified studies were also all observational studies (i.e., case-control or cohort), not clinical studies. We identified only one randomized control trial evaluating a community-based fall prevention program that provided older adults with medication education through pharmacy consultation (58) . Thus, additional clinical studies about this topic are encouraged.
Further, analyses are needed about the type (e.g., potency), doses, and duration of opioid use to better address differential effects of opioid use among older adults. Little is known about risks of long-term opioid use or polypharmacy with opioid medications, although these risks are known to lead to death and disabilities among older adults (59) . Therefore, future research is needed about associations of the temporal patterns on medication use, such as changes in opioid prescriptions and long-term prescriptions, with fall-related outcomes. Pooled logged-transformed effect sizes and 95% CIs of the associations of opioids with fall, fall injury, and fracture *female participants, **male participants NOTE: effect sizes estimated by opioid potency (Buckeridge, 2010) F2,33 = 2.34, p = 0.11 (The hypothesis testing that heterogeneity between groups is greater than that within groups.) Figure 3 . Pooled logged-transformed effect sizes and 95% CIs of the associations between opioid use and fracture/hip fracture by dosage
